Charles Kerbage

Title: Charles Kerbage: Innovator in Amyloid Protein Detection

Introduction

Charles Kerbage is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of amyloid proteins. With a total of 2 patents to his name, Kerbage's work is paving the way for advancements in understanding amyloidogenic disorders.

Latest Patents

Kerbage's latest patents focus on a system and method for detecting amyloid proteins in the eyes of mammals. The invention involves illuminating the eye with a light source that possesses specific wavelength and polarization properties. This method is designed to produce fluorescence in an amyloid-binding compound when it is bound to the amyloid protein. The compound is introduced to the eye and specifically binds to the amyloid protein, which is indicative of amyloidogenic disorders. The process includes determining a time decay rate of fluorescence, allowing for the distinction of the presence of the amyloid-binding compound in the eye based on this rate.

Career Highlights

Charles Kerbage is currently associated with Cognoptix, Inc., a company that focuses on innovative solutions in the field of eye diagnostics. His work at Cognoptix has been instrumental in developing technologies that enhance the detection of amyloid proteins, which are crucial in diagnosing various neurodegenerative diseases.

Collaborations

Kerbage has collaborated with notable colleagues such as Paul D. Hartung and Vincent Valvo. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Charles Kerbage's innovative work in the detection of amyloid proteins represents a significant advancement in medical diagnostics. His contributions are essential for improving the understanding and diagnosis of amyloidogenic disorders.